Heikal Shimaa A, Salama Mohamed, Richard Yuliya, Moustafa Ahmed A, Lawlor Brian
Institute of Global Health and Human Ecology (IGHHE), The American University in Cairo (AUC), New Cairo, Egypt.
Medical Experimental Research Center (MERC), Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Front Aging Neurosci. 2022 Feb 7;14:774005. doi: 10.3389/fnagi.2022.774005. eCollection 2022.
To help address the increasing challenges related to the provision of dementia care, dementia registries have emerged around the world as important tools to gain insights and a better understanding of the disease process. Dementia registries provide a valuable source of standardized data collected from a large number of patients. This review explores the published research relating to different dementia registries around the world and discusses how these registries have improved our knowledge and understanding of the incidence, prevalence, risk factors, mortality, diagnosis, and management of dementia. A number of the best-known dementia registries with high research output including SveDem, NACC, ReDeGi, CREDOS and PRODEM were selected to study the publication output based on their data, investigate the key findings of these registry-based studies. Registries data contributed to understanding many aspects of the disease including disease prevalence in specific areas, patient characteristics and how they differ in populations, mortality risks, as well as the disease risk factors. Registries data impacted the quality of patients' lives through determining the best treatment strategy for a patient based on previous patient outcomes. In conclusion, registries have significantly advanced scientific knowledge and understanding of dementia and impacted policy, clinical practice care delivery.
为应对与提供痴呆症护理相关的日益增加的挑战,痴呆症登记处已在全球范围内出现,成为获取见解和更好理解疾病进程的重要工具。痴呆症登记处提供了从大量患者收集的标准化数据的宝贵来源。本综述探讨了世界各地不同痴呆症登记处的已发表研究,并讨论了这些登记处如何增进了我们对痴呆症的发病率、患病率、风险因素、死亡率、诊断和管理的认识和理解。基于其数据,选取了一些研究产出高的最知名痴呆症登记处,包括瑞典痴呆症登记处(SveDem)、美国国家阿尔茨海默病协调中心(NACC)、德国痴呆症登记处(ReDeGi)、欧洲痴呆症研究合作组织(CREDOS)和葡萄牙痴呆症登记处(PRODEM),以研究其发表产出,调查这些基于登记处的研究的关键发现。登记处数据有助于理解该疾病的许多方面,包括特定地区的疾病患病率、患者特征及其在不同人群中的差异、死亡风险以及疾病风险因素。登记处数据通过根据既往患者结局为患者确定最佳治疗策略,影响了患者的生活质量。总之,登记处显著推进了对痴呆症的科学认识和理解,并影响了政策、临床实践护理提供。